ArticleCancer research communications2026
Associations between Sugar-Sweetened Beverage Intake and Metabolic Syndrome among Postmenopausal Black Women with Obesity and a Family History of Breast Cancer.
Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sugar-sweetened beverage (SSB) consumption is linked to increased metabolic syndrome (MetS) and breast cancer risk. This cross-sectional study examined associations between SSB intake and MetS by family history of breast cancer among postmenopausal Black women with obesity. Baseline data of 210 participants from the Focused Intervention on Exercise to Reduce CancEr (FIERCE) clinical trial were used. SSB intake was assessed with the Block 2005 Food Frequency Questionnaire, and family history of breast cancer was collected via a self-report questionnaire. Women with a family history of breast cancer who had high (vs. low) SSB intake had higher triglycerides (29.69 mg/dL higher, P = 0.011), lower high-density lipoprotein cholesterol (7.94 mg/dL lower, P = 0.027), and a higher MetS z-score (1.89 U higher, P < 0.001). Adjusting for relevant covariates, greater SSB intake predicted a higher MetS z-score (b = 0.01, Pinteraction = 0.031) and fasting glucose (b = 0.02, Pinteraction = 0.013) compared with lower SSB intake, only in women with a family history of breast cancer. Greater consumption of SSB subtypes (sugary juices, iced tea, and others) were associated with higher triglycerides, fasting glucose, and/or MetS z-score compared with lower consumption, only in women with a family history of breast cancer (Pinteractions < 0.05). Higher SSB consumption is linked to higher fasting glucose, triglycerides, and overall MetS risk in postmenopausal Black women with a family history of breast cancer. Targeted multilevel interventions to reduce SSB consumption and improve metabolic health in this population are warranted. SIGNIFICANCE: Higher SSB consumption was linked to higher fasting glucose, triglycerides, and overall MetS risk in postmenopausal Black women with a family history of breast cancer, but not in women without this family history. Findings highlight important heterogeneity in metabolic vulnerability and the need for culturally informed multilevel interventions, such as those targeting healthcare providers and individual decision making, to reduce SSB intake in vulnerable populations with a family history of breast cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.